Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v32-FR | Version v4-EN | |
---|---|---|
Language | French | English |
Date Updated | 2023-03-30 | 2022-07-13 |
Drug Identification Number | 02068036 | 02068036 |
Brand name | SABRIL | SABRIL |
Common or Proper name | vigabatrin powder for oral solution | vigabatrin powder for oral solution |
Company Name | LUNDBECK PHARMACEUTICALS LLC | LUNDBECK PHARMACEUTICALS LLC |
Ingredients | VIGABATRIN | VIGABATRIN |
Strength(s) | 500MG | 500MG |
Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
Route of administration | ORAL ORAL | ORAL ORAL |
Packaging size | Cartons of 50 | Cartons of 50 |
ATC code | N03AG | N03AG |
ATC description | ANTIEPILEPTICS | ANTIEPILEPTICS |
Reason for shortage | Requirements related to complying with good manufacturing practices. | Requirements related to complying with good manufacturing practices. |
Anticipated start date | 2022-09-07 | 2022-08-01 |
Actual start date | 2022-09-08 | |
Estimated end date | 2023-03-22 | Unknown |
Actual end date | 2023-03-22 | |
Shortage status | Resolved | Anticipated shortage |
Tier 3 Status | Yes | No |
Company comments | Very limited orders (432 unites) for the US-labelled Sabril for Oral Solution can be placed through Ashfield Healthcare. Pharmacies can register with Ashfield Healthcare by emailing jennifer.santangelo@ashfieldhealthcare.com or calling 1-514-630-7484 and referencing the Lundbeck Sabril Program. The pharmacy will be required to provide their full address and license number. Once registered, Ashfield will send out a weekly solicitation to all pharmacies in network with instructions on how to order the product | |
Health Canada comments |